Promoting endogenous iron mediated ferroptosis for cancer therapy through gene interference and reactive oxygen species amplification
- 18 December 2025
- journal article
- Published by Elsevier in Journal of Colloid and Interface Science
- Vol. 707, 139717
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- GSH/pH Dual Activatable Cross‐linked and Fluorinated PEI for Cancer Gene Therapy Through Endogenous Iron De‐Hijacking and in Situ ROS AmplificationAdvanced Materials, 2023
- Electrostatic Attractive Self‐Delivery of siRNA and Light‐Induced Self‐Escape for Synergistic Gene TherapyAdvanced Materials, 2023
- Ferritin‐Hijacking Nanoparticles Spatiotemporally Directing Endogenous Ferroptosis for Synergistic Anticancer TherapyAdvanced Materials, 2022
- Unprotonatable and ROS‐Sensitive Nanocarrier for NIR Spatially Activated siRNA Therapy with Synergistic Drug EffectSmall, 2022
- An ROS‐Activatable Nanoassembly Remodulates Tumor Cell Metabolism for Enhanced Ferroptosis TherapyAdvanced Healthcare Materials, 2021
- Hydroxyl radical-involved cancer therapy via Fenton reactionsFrontiers of Chemical Science and Engineering, 2021
- Towards applications of bioentities@MOFs in biomedicineCoordination Chemistry Reviews, 2021
- Redox Responsive Metal Organic Framework Nanoparticles Induces Ferroptosis for Cancer TherapySmall, 2020
- Oxidative Stress in CancerCancer Cell, 2020
- Stabilization of antibody structure upon association to a human carbonic anhydrase IX epitope studied by X‐ray crystallography, microcalorimetry, and molecular dynamics simulationsProteins: Structure, Function, and Bioinformatics, 2007